Imagine detecting cancer years before symptoms even appear, all from a simple blood test. You'll learn how cutting-edge liquid biopsies are making this a reality, potentially revolutionizing early cancer detection.
The global liquid biopsy market is projected to reach nearly $10 billion by 2028, reflecting a massive shift towards less invasive cancer detection methods.
This growth is driven by advancements in genomic sequencing and a push for earlier, more accessible cancer screening.